1. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review

   • Shiva Sharifzadeh
   • Amir Hooshang Mohammadpour
   • Sepideh Elyasi

   Review 06 October 2020 Pages: 275 - 289

   

2. Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis

   • Janthima Methaneethorn
   • Nattawut Leelakanok

   Review 19 October 2020 Pages: 291 - 309

   

3. Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies

   • Meng Zhao
   • Jieyu Lu
   • Yanhu Wu

   Review 13 October 2020 Pages: 311 - 319

   

4. Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis

   • Sylvaine Bœuf-Gibot
   • Bruno Pereira
   • Hélène Vaillant-Roussel

   Review 17 October 2020 Pages: 321 - 329

   

5. Potentially inappropriate medication in older psychiatric patients

   • Gudrun Hefner
   • Martina Hahn
   • Ansgar Klimke

   Clinical Trial 08 October 2020 Pages: 331 - 339

   

6. A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management

   • Charlotte S. Yang
   • Rosaleen Boswell
   • Tammy J. Bungard

   Pharmacodynamics 06 January 2021 Pages: 341 - 348

   

7. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis

   • Mengyuan Liu
   • Fangfang Fan
   • Jianping Li

   Pharmacogenetics Open access 13 October 2020 Pages: 349 - 357

   

8. Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease

   • Kong-Xiang Zhu
   • Pei-Yuan Song
   • Xiao-Ping Chen

   Pharmacogenetics 21 October 2020 Pages: 359 - 368

   

9. Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder

   • Yumi Imoto
   • Takafumi Naito
   • Junichi Kawakami

   Pharmacokinetics and Disposition 08 October 2020 Pages: 369 - 379

   

10. Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer

    • Yoshitaka Saito
    • Yoh Takekuma
    • Mitsuru Sugawara

    Pharmacokinetics and Disposition 07 October 2020 Pages: 381 - 388

    

11. Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients

    • Jean Claude Alvarez
    • Pierre Moine
    • on behalf of the Garches COVID-19 Collaborative Group*Ambrosi, Xavier, Amthor, Suzanne, Bounab, Rania, Chentouh, Ryme, Clair, Bernard, Fayssoil, Abdallah, Friedman, Diane, Heming, Nicholas, Maxime, Virginie, Niel Duriez, Myriam, Orlikowski, David, Santi, Francesca, Villart, Maryvonne, Michelon Hugues, Abbar, Baptiste, Dray, Juliah, Tamayo, Juan, Pascault, Alice, Zini; Justine, Bennington, Steven, Moucachen, Myriam, Gay, Pierre, Luxman, Majistor, Kochbati, Elias, Martinez, Valéria, Guichard, Léa, Trabelsi, Chawki, Boutros, Marie, Schitter, Sebastien, Meuleye, Simone, Reysz, Suzanne, Khiter, Hakim, Dosne Blachier, Brigitte, Bron, Anne Lyse, Defouchecour, Etiennette, Hamon Pietrin, Damien, Coester, Denys, Bergounioux Jean, Omar, Amal, Guillon, Maud, Amthor, Helge, Prigent, Helene, Lofaso, Frédéric, Denys Pierre, Bensmail, Djamel, Joussain, Charles, Malot, Claire, Lansaman, Thibaut, Leotard, Antoine, Le Liepvre, Hélène, Rech, Celia, Paquereau, Julie, Kagane, Lauren, Levy, Jonathan, Chkron, Elsa, Angioni, Florence, Karabulut, Céline, Lemoine, Jérôme, Vibert, Julien, Trystram, Noémie, Christian Perronne, Véronique Perronne, Aurélien Dinh, Pierre de Truchis, Soline Simeon, Bessis Simon, Morgan Matt, Hélène Mascitti, Stéphanie Landowski, Pascal Crenn, Aurélie Le Gal, Aymeric Lanore, Julia Nguyen Van Thang, Louis Jacob, Nicolas Kiavue, Marc Hobeika, Jean Louis Gaillard, Jean Louis Hermann, Martin Rottman, Anne Laure Roux, Marie-Anne Welti, Elyanne Gault, Christine Lawrence

    Pharmacokinetics and Disposition 13 October 2020 Pages: 389 - 397

    

12. Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study

    • Jia-Li Feng
    • Xiwen Qin

    Pharmacoepidemiology and Prescription 08 October 2020 Pages: 399 - 407

    

13. Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients

    • Johan Holm
    • Buster Mannheimer
    • Jonatan D Lindh

    Pharmacoepidemiology and Prescription Open access 07 October 2020 Pages: 409 - 419

    

14. Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme

    • David J. Brinkman
    • Teresa Monteiro
    • Jelle Tichelaar

    Pharmacoepidemiology and Prescription Open access 23 October 2020 Pages: 421 - 429

15. Presence of the aldehyde dehydrogenase 2 variant ALDH2*2 considerably increases EC₅₀ of nitroglycerin

    • Kentaro Ushijima
    • Chika Ogami
    • Akio Fujimura

    Letter to the Editor 10 October 2020 Pages: 431 - 433

    

16. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19

    • Chia Siang Kow
    • Mamoon Aldeyab
    • Syed Shahzad Hasan

    Letter to the Editor 04 October 2020 Pages: 435 - 437

17. Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication

    • Olorunfemi A. Oshagbemi
    • Abraham Daniel
    • Ismaeel Yunusa

    Letter to the Editor 20 October 2020 Pages: 439 - 440